Skip to main content
. 2014 Aug 5;14:14. doi: 10.1186/1471-5945-14-14

Figure 1.

Figure 1

Study design. *Patients/physicians remained blinded to initial randomized treatment groups until end of open-label period. Primary endpoint was percent of patients achieving clear or almost clear status on PGA of psoriasis at week 12. BIW: twice weekly; ETN: etanercept; PGA: Physician Global Assessment; QW: once weekly.